type_of_cancer: pcnsl
cancer_study_identifier: pcnsl_msk_2024
name: Primary CNS Lymphoma - Ibrutinib Long Term Follow Up (MSK, Cancer Cell 2024)
description: A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma.
citation: Caitlin A et al. Cancer Cell 2024
pmid: 39214094